These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 16019351)

  • 21. A relative reduction in mid-follicular LH concentrations during GnRH agonist IVF/ICSI cycles leads to lower live birth rates.
    Lahoud R; Al-Jefout M; Tyler J; Ryan J; Driscoll G
    Hum Reprod; 2006 Oct; 21(10):2645-9. PubMed ID: 16785261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of ovarian high response on implantation and pregnancy outcome during controlled ovarian hyperstimulation (with GnRH agonist and rFSH).
    Chen QJ; Sun XX; Li L; Gao XH; Wu Y; Gemzell-Danielsson K; Cheng LN
    Acta Obstet Gynecol Scand; 2007; 86(7):849-54. PubMed ID: 17611831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical effects of oocyte cryopreservation in assisted reproduction technology].
    Wang W; Yan ZJ; Cai LB; Chai DC; Liu CZ; Mao YD; Liu JY
    Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(39):2755-8. PubMed ID: 19080449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patients with three or less dominant follicles may not be associated with reduced pregnancy rate of in vitro fertilization treatment.
    Ng EH; Yeung WS; Ho PC
    Eur J Obstet Gynecol Reprod Biol; 2006 Nov; 129(1):54-9. PubMed ID: 16584831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controlled ovarian hyperstimulation: does prolonged stimulation justify cancellation of in vitro fertilization cycles?
    Bar-Hava I; Yoeli R; Yulzari-Roll V; Ashkenazi J; Shalev J; Orvieto R
    Gynecol Endocrinol; 2005 Oct; 21(4):232-4. PubMed ID: 16316846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial.
    Andersen AN; Devroey P; Arce JC
    Hum Reprod; 2006 Dec; 21(12):3217-27. PubMed ID: 16873892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ovarian endometriomas: Effect of laparoscopic cystectomy on ovarian response in IVF-ET cycles].
    Yazbeck C; Madelenat P; Sifer C; Hazout A; Poncelet C
    Gynecol Obstet Fertil; 2006 Sep; 34(9):808-12. PubMed ID: 16920378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical significance of the retrieval of a low number of oocytes following mild ovarian stimulation for IVF: a meta-analysis.
    Verberg MF; Eijkemans MJ; Macklon NS; Heijnen EM; Baart EB; Hohmann FP; Fauser BC; Broekmans FJ
    Hum Reprod Update; 2009; 15(1):5-12. PubMed ID: 19091754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is recombinant follicle-stimulating hormone more effective in IVF poor responders than human menopausal gonadotrophins?
    Eskandar M; Jaroudi K; Jambi A; Archibong EI; Coskun S; Sobande AA
    Med Sci Monit; 2004 Jan; 10(1):PI6-9. PubMed ID: 14704644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The number of retrieved oocytes does not decrease during consecutive gonadotrophin-stimulated IVF cycles.
    de Boer EJ; Den Tonkelaar I; Burger CW; Looman CW; van Leeuwen FE; te Velde ER;
    Hum Reprod; 2004 Apr; 19(4):899-904. PubMed ID: 14990545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of withholding gonadotropin (a coasting period) on the outcome of in vitro fertilization cycles.
    Owj M; Tehrani Nejad ESh; Amirchaghmaghi E; Ezabadi Z; Baghestani AR
    Eur J Obstet Gynecol Reprod Biol; 2007 Jul; 133(1):81-5. PubMed ID: 17229513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dynamic assay of serum inhibin B and estradiol concentrations obtained after gonadotrophin therapy as predictors of ovarian response in vitro fertilization cycle].
    Miao MF; Huang HF
    Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):114-7. PubMed ID: 16640861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "Ovarian age-based" stimulation of young women with diminished ovarian reserve results in excellent pregnancy rates with in vitro fertilization.
    Gleicher N; Barad D
    Fertil Steril; 2006 Dec; 86(6):1621-5. PubMed ID: 17074322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defining poor ovarian response during IVF cycles, in women aged <40 years, and its relationship with treatment outcome.
    Kailasam C; Keay SD; Wilson P; Ford WC; Jenkins JM
    Hum Reprod; 2004 Jul; 19(7):1544-7. PubMed ID: 15142994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ovarian stimulation for IVF has no quantitative association with birthweight: a registry study.
    Griesinger G; Kolibianakis EM; Diedrich K; Ludwig M
    Hum Reprod; 2008 Nov; 23(11):2549-54. PubMed ID: 18684734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of gonadotropin-releasing hormone agonist/recombinant follicle-stimulating hormone versus gonadotropin-releasing hormone antagonist/recombinant follicle-stimulating hormone on follicular fluid levels of adhesion molecules during in vitro fertilization.
    Fornaro F; Cobellis L; Mele D; Tassou A; Badolati B; Sorrentino S; De Lucia D; Colacurci N
    Fertil Steril; 2007 Jan; 87(1):39-47. PubMed ID: 17084393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol?
    Schoolcraft WB; Surrey ES; Minjarez DA; Stevens JM; Gardner DK
    Fertil Steril; 2008 Jan; 89(1):151-6. PubMed ID: 17482177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of recombinant human luteinizing hormone supplementation on ovarian stimulation and the implantation rate in down-regulated women of advanced reproductive age.
    Fábregues F; Creus M; Peñarrubia J; Manau D; Vanrell JA; Balasch J
    Fertil Steril; 2006 Apr; 85(4):925-31. PubMed ID: 16580376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Addition of estradiol to progesterone for luteal supplementation in patients stimulated with GnRH antagonist/rFSH for IVF: a randomized controlled trial.
    Fatemi HM; Kolibianakis EM; Camus M; Tournaye H; Donoso P; Papanikolaou E; Devroey P
    Hum Reprod; 2006 Oct; 21(10):2628-32. PubMed ID: 16857887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does plasma insulin level affect ovarian response to exogenous administration of follicle-stimulating hormone in women without polycystic ovary syndrome?
    La Marca A; Pati M; Giulini S; Levratti P; Caretto S; Volpe A
    Gynecol Endocrinol; 2005 Nov; 21(5):292-4. PubMed ID: 16373249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.